UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000017828
Receipt No. R000020652
Scientific Title Phase II trial of the addition of bevacizumab to alectinib beyond progressive disease in ALK-positive advanced non-small-cell lung cancer.
Date of disclosure of the study information 2015/06/05
Last modified on 2019/02/22 16:01:26

No. Disposal Last modified on Item of update
1 Insert 2015/06/05 22:06:51
2 Update 2015/06/05 22:09:57 Recruitment status
3 Update 2016/06/05 09:46:34 Name of primary sponsor
Organization
4 Update 2019/02/22 16:01:26 Recruitment status


Contact us.